Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.COWbVb-l.js ...

It will allow swift transport links to GSK's main R&D campus in Stevenage – where the company is also developing a new bioscience cluster – and will also be close to its artificial ...

Based near GSK’s research base in Stevenage, KaNDy was spun out of NeRRe Therapeutics in 2017, itself a spin-off from the big UK pharma following its decision to withdraw from neuroscience R&D ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

After hours: February 3 at 6:25:46 p.m. EST ...

24 Jul, 2018 11 Sep, 2018 1:1 For every 1 share held; Holder will receive 1 bonus shares. 28 Sep, 1994 02 Jan, 1995 1:1 For every 1 share held; Holder will receive 1 bonus shares. 23 Jun, 1980-1:3 ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...